✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
ASP0456 is an investigational drug.
There have been 6 clinical trials for ASP0456. The most recent clinical trial was a Phase 3 trial, which was initiated on October 21st 2014.
The most common disease conditions in clinical trials are Constipation, Syndrome, and Irritable Bowel Syndrome. The leading clinical trial sponsors are Astellas Pharma Inc and [disabled in preview].
There are one hundred and eighty-seven US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for ASP0456
|A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation||Astellas Pharma Inc||Phase 3|
|A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation||Astellas Pharma Inc||Phase 2|
|Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome||Astellas Pharma Inc||Phase 3|
Top disease conditions for ASP0456
Top clinical trial sponsors for ASP0456
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|ASP0456||See Plans and Pricing||Ultra-pure agonists of guanylate cyclase C, method of making and using same||SYNERGY PHARMACEUTICALS, INC. (New York, NY)||See Plans and Pricing|
|ASP0456||See Plans and Pricing||Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide||Alkermes, Inc. (Waltham, MA)||See Plans and Pricing|
|ASP0456||See Plans and Pricing||Formulations of guanylate cyclase C agonists and methods of use||SYNERGY PHARMACEUTICALS, INC. (New York, NY)||See Plans and Pricing|
|ASP0456||See Plans and Pricing||Benzazole compounds and methods for making and using the compounds||Rigel Pharmaceuticals, Inc. (South San Francisco, CA)||See Plans and Pricing|
|ASP0456||See Plans and Pricing||Compositions and methods for inducing urinary voiding and defecation||Dignify Therapeutics, LLC (Research Triangle Park, NC)||See Plans and Pricing|
|ASP0456||See Plans and Pricing||Method for treating constipation||GELESIS LLC (Boston, MA)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|ASP0456||Australia||AU2014274812||2033-06-05||See Plans and Pricing|
|ASP0456||Australia||AU2018226473||2033-06-05||See Plans and Pricing|
|ASP0456||Australia||AU2020205349||2033-06-05||See Plans and Pricing|
|ASP0456||Canada||CA2913737||2033-06-05||See Plans and Pricing|
|ASP0456||China||CN105764916||2033-06-05||See Plans and Pricing|
|ASP0456||China||CN113388007||2033-06-05||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|